- Nachrichtendetail
-
21.02.2024 13:12:52 - dpa-AFX: *REGENERON PHARMA: FDA ACCEPTS FOR PRIORITY REVIEW BLA FOR LINVOSELTAMAB FOR TREATMENT OF R/R MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 952,800 | 14.06.24 08:05:16 | -3,200 | -0,33% | 967,000 | 972,200 | 952,800 | 956,000 |
